Honglai L. Zhang
Qingdao, 266035, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Leveraging protein language models for robust antimicrobial peptide detection.
Journal: Methods (San Diego, Calif.)
Published: January 15, 2025
Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: March 07, 2022
Eukaryotic translation initiation factor 5A in the pathogenesis of cancers.
Journal: Oncology letters
Published: March 12, 2020
Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells.
Journal: Thyroid research
Published: July 11, 2018
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: May 24, 2018
The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: May 09, 2018
Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity.
Journal: Genetics and molecular research : GMR
Published: September 25, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026